LTB4 in expired breath condensate and sputum supernatant in patients with COPD. The effects of reversibility Source: Eur Respir J 2003; 22: Suppl. 45, 476s Year: 2003
Exhaled breath condensate total NOx in chronic lung disease in response to changes in ambient air pollution Source: Annual Congress 2007 - What's new in air pollution from experiments to epidemiology Year: 2007
Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006
Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004
Possible use of exhaled breath condensate (EBC) for continuous monitoring of lung inflammation in artificial ventilation Source: Eur Respir J 2002; 20: Suppl. 38, 85s Year: 2002
Effects of concentrated ambient air particles (CAPs) on markers of airways inflammation in exhaled breath condensate of healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 237s Year: 2004
Biomarkers of COPD severity in expired air condensate Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
The physiological concentration of nitrite in exhaled breath condensate, broncho-alveolar lavage fluid and blood samples Source: Eur Respir J 2004; 24: Suppl. 48, 402s Year: 2004
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
The influence of active and passive air humidification on exhaled breath condensate volume Source: ERJ Open Res, 6 (4) 00009-2020; 10.1183/23120541.00009-2020 Year: 2020
Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Does human exposure to carbon particles and sulphur dioxide produce adverse changes in markers of inflammation in exhaled breath condensate, nasal lavage or serum? Source: Eur Respir J 2004; 24: Suppl. 48, 604s Year: 2004
Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients Source: Eur Respir J, 58 (2) 2003024; 10.1183/13993003.03024-2020 Year: 2021
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Expired breath condensate H2 O2 correlates with bronchoalveolar lavage neutrophilia Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air Year: 2003
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004
Exhaled breath condensate pH standardised for CO2 partial pressure Source: Eur Respir J 2007; 29: 496-501 Year: 2007
pH in expired breath condensate of patients with inflammatory airway diseases Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Influence of smoking on indicators of free-radical oxidation in a condensate in exhaled breath condensate (EBC) at healthy and patients with bronchial asthma (BA) Source: Annual Congress 2010 - Smoking related disorders Year: 2010
8-isoprostane in exhaled breath condensate (EBC) and air pollution exposure in children with wheezing Source: Annual Congress 2012 - Indoor and outdoor air pollution Year: 2012